Related Experiment Video
Updated: Oct 18, 2025
08:59
An Intestine/Liver Microphysiological System for Drug Pharmacokinetic and Toxicological Assessment
Published on: December 3, 2020
8.1K
A Systematic Approach to Pregnancy-Specific Liver Disorders
Dhruv Verma1, Adelaide M Saab2, Sammy Saab1,2
1Department of Medicine, University of California at Los Angeles, Los Angeles, California.
Gastroenterology & Hepatology
|October 4, 2021
Summary
Diagnosing liver disease in pregnancy requires distinguishing between pregnancy-specific conditions and those unrelated to pregnancy. A systematic approach ensures timely diagnosis and management for better maternal and fetal outcomes.
Area of Science:
- Hepatology
- Obstetrics
- Maternal-Fetal Medicine
Background:
- Physiologic changes in pregnancy can mimic liver disease, complicating diagnosis.
- Pregnancy-specific liver disorders are a significant cause of abnormal liver function tests.
- Non-pregnancy-specific liver diseases affect up to 3% of pregnant women.
Purpose of the Study:
- To outline a systematic approach for diagnosing and managing liver disease in pregnancy.
- To differentiate between pregnancy-specific and non-pregnancy-specific liver disorders.
- To improve maternal and fetal outcomes through timely intervention.
Main Methods:
- Reviewing normal pregnancy-related liver function changes.
- Excluding non-pregnancy-related liver diseases.
- Utilizing clinical clues and trimester status for diagnosis.
- Implementing timely treatment strategies.
Main Results:
- Pregnancy-specific liver disorders can lead to severe maternal and fetal morbidity and mortality.
- Maternal prognosis depends on liver disease type, function impairment, and delivery timing.
- A structured diagnostic process is crucial for effective management.
Conclusions:
- Effective management of liver disease in pregnancy hinges on accurate diagnosis.
- Understanding pregnancy's impact on liver function is key.
- A systematic, trimester-aware approach enhances patient care and outcomes.
Related Concept Videos
01:22Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test
28
In clinical practice, the direct measurement of hepatic blood flow to evaluate liver function presents significant challenges due to the intricate and specialized nature of the necessary techniques. Consequently, healthcare professionals often rely on empirical estimates derived from thorough patient examinations and liver function tests to gauge liver health. Among the tools at their disposal, the Child–Pugh and MELD scoring systems stand out for their ability to categorize and assess...
28
01:26Diseases of the Liver and Gallbladder
1.4K
Liver and gallbladder diseases are a significant health concern, with prominent conditions including cirrhosis, hepatitis, non-alcoholic fatty liver disease (NAFLD), and gallstones. Jaundice is a common manifestation of liver and biliary disease.
Cirrhosis is characterized by the scarring of hepatic lobules in the liver, which are replaced by fibrous tissue, affecting the liver's normal functioning. NAFLD, on the other hand, is caused by an excessive build-up of fat in the liver, not...
Cirrhosis is characterized by the scarring of hepatic lobules in the liver, which are replaced by fibrous tissue, affecting the liver's normal functioning. NAFLD, on the other hand, is caused by an excessive build-up of fat in the liver, not...
1.4K
01:26Effect of Hepatic Disease on Pharmacokinetics: Drug Dosing and Hepatic Blood Flow
26
Chronic liver disease significantly impacts drug metabolism due to alterations in hepatic blood flow and enzyme accessibility. This disruption affects the body's pharmacokinetics—the movement and processing of drugs within the system. Key enzymes crucial for metabolizing medications become less accessible, changing how drugs are processed and utilized. Furthermore, liver disease influences the synthesis of plasma proteins, such as albumin and globulins, which play critical roles in drug...
26
01:30Liver Physiology
2.0K
The liver, an essential organ in the human body, performs over 200 vital functions that can be broadly categorized into metabolic, hematological, endocrine regulation, and bile production.
Metabolic Regulation:
The liver is the central organ involved in regulating blood composition. It stabilizes blood glucose levels, maintaining them within the range of 70–110 mg/dL. When these levels drop, the liver breaks down glycogen reserves and releases glucose into the bloodstream. It can...
Metabolic Regulation:
The liver is the central organ involved in regulating blood composition. It stabilizes blood glucose levels, maintaining them within the range of 70–110 mg/dL. When these levels drop, the liver breaks down glycogen reserves and releases glucose into the bloodstream. It can...
2.0K
01:14Effect of Hepatic Disease on Pharmacokinetics: Active Drug, Metabolite and Fraction of Metabolized Drug
21
In pharmacotherapy, monitoring drug concentrations is paramount, especially for drugs whose therapeutic effects hinge on both the active compound and its metabolite. Hepatic impairment profoundly influences drug potency by altering liver function. If the drug is more potent than its metabolite, impaired liver function amplifies drug activity due to elevated drug concentration levels. Conversely, if the metabolite holds greater potency, diminished liver function diminishes drug activity by...
21
01:08Effect of Hepatic Disease on Pharmacokinetics: Dose Adjustments Due to Hepatic Impairment
31
Hepatic impairment, characterized by decreased liver function, does not uniformly mandate adjustments in drug dosage. Whether dosage modifications are necessary depends on various factors related to the drug's metabolism and elimination pathways. If a drug is primarily excreted via the kidneys and bypasses significant hepatic processing, if it undergoes minimal metabolic transformation in the liver, or if it is volatile and primarily expelled through the lungs, dose adjustments may not be...
31